Topics

Takeda’s Dengue Vaccine is Promising, but Critics Still Have Concerns

19:00 EST 6 Nov 2019 | BioSpace

Although the results look very promising, there are still concerns similar to those seen with Sanofi’s Dengvaxia.

Original Article: Takeda’s Dengue Vaccine is Promising, but Critics Still Have Concerns

NEXT ARTICLE

More From BioPortfolio on "Takeda’s Dengue Vaccine is Promising, but Critics Still Have Concerns"

Quick Search

Relevant Topic

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...